Catalent, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • May 5th, 2014 • Catalent, Inc. • Pharmaceutical preparations • New York
Catalent, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [—] shares of common stock, par value $0.01 per share (the “Stock”), of the Company. The aggregate of [—] shares of Stock to be sold by the Company are herein called the “Firm Shares” and the aggregate of up to [—] additional shares of Stock to be sold by the Company are herein called the “Optional Shares.” The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares.”
STOCKHOLDERS AGREEMENT DATED AS OF [ ], 2014 AMONG CATALENT, INC. BLACKSTONE HEALTHCARE PARTNERS L.L.C. AND PHOENIX CHARTER LLCStockholders Agreement • May 5th, 2014 • Catalent, Inc. • Pharmaceutical preparations • Delaware
This Stockholders Agreement is entered into as of [ ], 2014 by and among Catalent, Inc., a Delaware corporation (the “Company”), and each of the other parties identified on the signature pages hereto (the “Investor Parties”).
